Walvax Biotechnology announces senior management changes, restructuring

Walvax Biotechnology Co., Ltd. (SZSE:300142) announced a series of senior management changes aimed at optimizing its organizational structure and driving strategic transformation. Effective June 16, 2025, the board approved the appointment of Li Wei and Liu Yuran as Vice Presidents. Li Wei will oversee key product manufacturing and quality management, while Liu Yuran will be responsible for major project financing, legal compliance, and audit supervision.